25.4 Statement of comprehensive income
Impact of various categories of financial instruments on financial income and costs
| Year ended December 31, 2022 (in PLNm) |
Cash and cash equivalents | Other financial assets | Shares and other equity instruments | Financial instruments measured at fair value |
Hedging derivatives | Other financial liabilities | TOTAL |
|---|---|---|---|---|---|---|---|
| Dividends | – | – | 4 | – | – | – | 4 |
| Interest income / (costs) | 343 | 109 | – | – | 108 | (413) | 147 |
| Impairment | – | – | (7) | 3 | – | – | (4) |
| Reversal/(recognition) of impairment | – | (5) | (4) | – | – | – | (9) |
| Exchange differences | 4 | 26 | – | – | – | (56) | (26) |
| Gain / (loss) on sale of investment | – | – | 37 | – | – | – | 37 |
| Settlement of loss of control | – | – | (1) | – | – | – | (1) |
| TOTAL PROFIT/ (LOSS) | 347 | 130 | 29 | 3 | 108 | (469) | 148 |
| Year ended December 31, 2021 (in PLNm) |
Cash and cash equivalents | Other financial assets | Shares and other equity instruments | Financial instruments measured at fair value |
Hedging derivatives | Other financial liabilities | TOTAL |
|---|---|---|---|---|---|---|---|
| Dividends | – | – | 3 | – | – | – | 3 |
| Interest income / (costs) | 1 | 16 | – | – | (129) | (195) | (307) |
| Impairment | – | – | – | (2) | (31) | – | (33) |
| Reversal/(recognition) of impairment | – | (7) | – | – | – | – | (7) |
| Exchange differences | 1 | (18) | – | – | – | 13 | (4) |
| Gain / (loss) on sale of investment | – | – | (6) | – | – | – | (6) |
| Settlement of loss of control | – | – | 324 | – | – | – | 324 |
| TOTAL PROFIT/ (LOSS) | 2 | (9) | 321 | (2) | (160) | (182) | (30) |